Sectoral Asset Management Inc Novavax Inc Transaction History

Sectoral Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$18.2 - $76.12 $849,030 - $3.55 Million	-46,650 Reduced 94.82%	2,550 $46,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $47,164 - $97,877	-1,300 Reduced 2.57%	49,200 $2.53 Million
Q1 2022 May 10, 2022	BUY	$69.73 - $142.9 $432,326 - $885,980	6,200 Added 14.0%	50,500 $3.72 Million
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $6.08 Million - $9.84 Million	-45,150 Reduced 50.48%	44,300 $6.34 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $177,800 - $270,580	1,000 Added 1.13%	89,450 $18.5 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $12.4 Million - $26.5 Million	-102,750 Reduced 53.74%	88,450 $18.8 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $3.63 Million - $10.3 Million	-32,150 Reduced 14.39%	191,200 $34.7 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $8.28 Million - $14.7 Million	105,150 Added 88.96%	223,350 $24.9 Million
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $9.39 Million - $21.1 Million	118,200 New	118,200 $12.8 Million

287

94.6M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $660M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.